Lumentum vs Roivant Sciences Ltd. Common Shares — how do they compare? Lumentum trades at $1,103.36 (market cap $94.99B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Lumentum is far larger — about 3.8× Roivant Sciences Ltd. Common Shares's market cap, and Roivant Sciences Ltd. Common Shares is more actively traded (6,279,442 versus 4,855,776). Which is the better fit depends on your goals — on Pluang, investors hold Lumentum for 4 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| LITE | ROIV | |
|---|---|---|
Market Cap | $94.99B | $24.72B |
Volume | 4,855,776 | 6,279,442 |
Sector | Technology | Health |
52-Week High | $1.13K | $41.81 |
52-Week Low | $149.61 | $16.04 |
Typical Hold Time | 4 Days | 1 Days |
Enterprise Value | $93.92B | $20.99B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.
Read more on LITE →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →